Medistim ASA (MEDI.OL) Financials
MEDI.OL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 660.6 million | 192.2 million |
| Sept. 30, 2025 | 575.2 million | 156.6 million |
| June 30, 2025 | 535.0 million | 151.2 million |
| March 31, 2025 | 617.3 million | 150.9 million |
MEDI.OL Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| Sept. 30, 2025 | 69.1 million | ? |
| June 30, 2025 | 37.7 million | ? |
| March 31, 2025 | 18.8 million | ? |
MEDI.OL Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 38.1 million |
| Sept. 30, 2025 | 34.7 million |
| June 30, 2025 | 56.3 million |
| March 31, 2025 | 56.7 million |
MEDI.OL Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 212.1 million | 75.0 million | 37.5 million |
| Sept. 30, 2025 | 157.7 million | 42.6 million | 21.3 million |
| June 30, 2025 | 96.4 million | 22.0 million | 22.0 million |
| March 31, 2025 | 183.4 million | 26.2 million | 26.2 million |
MEDI.OL Shares Outstanding
MEDI.OL Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 66.0 million | 10.9 million | 23.4 million | - |
| Sept. 30, 2025 | - | 6.1 million | 55.2 million | - |
| June 30, 2025 | - | 7.9 million | 22.7 million | - |
| March 31, 2025 | - | 8.6 million | 52.1 million | - |
MEDI.OL Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 182.3 million | 105.7 million |
| Sept. 30, 2025 | 166.8 million | 30.8 million |
| June 30, 2025 | 169.1 million | 30.6 million |
| March 31, 2025 | 181.5 million | 30.6 million |
MEDI.OL
Price: NOK228
Dividend Yield: 2.78%
Forward Dividend Yield: 3.43%
Payout Ratio: 79.09%
Dividend Per Share: 8.00 NOK
Earnings Per Share: 7.80 NOK
P/E Ratio: 27.44
Exchange: OSL
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 3.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 22
DGR3: 17.78%
DGR5: 30.00%